The Scientist

» professor and immunology

Most Recent

image: Yvonne Saenger: Immunotherapy Pioneer

Yvonne Saenger: Immunotherapy Pioneer

By | April 1, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

5 Comments

image: T Cells of the Skin

T Cells of the Skin

By | March 18, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

2 Comments

image: Fighting Allergy with Allergen

Fighting Allergy with Allergen

By | February 25, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

4 Comments

image: Long-Lived Immunotherapy Stem Cells

Long-Lived Immunotherapy Stem Cells

By | February 4, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

1 Comment

image: B Cell Bosses

B Cell Bosses

By | February 1, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

0 Comments

image: Stubbornly Persistent

Stubbornly Persistent

By | February 1, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

1 Comment

image: Thanks for the Memories

Thanks for the Memories

By | February 1, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

1 Comment

image: Viral Virtuosos

Viral Virtuosos

By | February 1, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

3 Comments

image: Interferon Discoverer Dies

Interferon Discoverer Dies

By | January 26, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

0 Comments

image: Inflammation Overdrive

Inflammation Overdrive

By | January 15, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

2 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech